BPC-157 is one of those molecules the research community talks about a lot while the approved answers stay thin. Let us walk through it calmly: what the peptide is, what labs actually study with it, and what to look at when you choose a reagent for work.

What BPC-157 is

It is a synthetic pentadecapeptide, a chain of 15 amino acids. Its sequence copies a fragment of a protective human gastric juice protein. A high proline content lets the molecule hold its shape and resist enzymatic breakdown. Formula C62H98N16O22, molar mass about 1419.5 g/mol.

What is studied with it

Most of the literature sits in cell cultures and animal models. Researchers look at connective-tissue healing of tendons and ligaments, at angiogenesis in a burn model, and at classic gastric mucosal cytoprotection. These are research directions, not proven effects in humans. There is no approved human protocol, and no regulator has cleared BPC-157 as a medicine.

One peptide or a combination

In research BPC-157 is used both on its own and together with TB-500. The idea behind the pairing is that the molecules act at different points of the repair process. We stock both options: standalone BPC-157, the ready combination BPC-157 and TB-500, and standalone TB-500.

How to check reagent quality

The main question about any peptide on the market is purity and whether it matches the label. Longeva sends samples itself to independent third-party labs, and batches ship with a COA (certificate of analysis) in an open archive. We do not call these labs accredited, because that would be untrue; they are independent, and that is what matters for verification.

Where to go next

The chemistry and sources are collected in the BPC-157 monograph. Reconstitution and literature dose ranges are on the BPC-157 dilution guide.

Research material. Not a medicinal product. Not medical advice.

Sources

  • Sikiric P, et al. Current Pharmaceutical Design, 2011. doi:10.2174/138161211796196954
  • Gwyer D, Wragg NM, Wilson SL. Cell and Tissue Research, 2019. doi:10.1007/s00441-019-03016-8
  • Huang T, et al. Drug Design, Development and Therapy, 2015. doi:10.2147/DDDT.S82030